Quentin Jacomet

BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA.

Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector.

Abénex Capital SAS is an Independent Private Equity firm founded in 1957 by Hervé Claquin. Abénex Capital is headquartered in Paris.

Omnes Capital SAS (Omnes Capital) is a private equity firm founded in 1984. The firm is headquartered in Paris, France with additional offices in Belgium, Switzerland, Germany.

GlaxoSmithKline SpA manufactures and distributes pharmaceutical products. The firm offers prescription pharmaceuticals and vaccines, over-the-counter medicines, oral care and nutritional healthcare products. The company was founded on March 30, 1932 and is headquartered in Verona, Italy.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.

Siparex XAnge Venture SAS is an Independent Venture Capital firm founded in 1977 by Benjamin Teszner. Siparex XAnge Venture SAS is headquartered in Paris.

Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa.

Kayentis SAS provides software in clinical trials solutions. It publishes and operates digital pen and smart paper solutions for the healthcare industry. The firm provides eCOA and eCRF solutions for trial management. It operates through its offices located in Gif-sur-Yvette and Saint Louis. The company was founded by Philippe Berna in 2009 and is headquartered in Gif-sur-Yvette, France.

Eye Tech Care SA develops medical devices for non-invasive eye disease treatment. It offers an ultrasound device which offers a non-invasive treatment that utilizes the ultrasound circular cyclo-coagulation procedure that reduces the intraocular pressure in refractory glaucoma. The firm serves the ophthalmology market in France and Europe. The company was founded by Fabrice Romano, Laurent Farcy and Philippe Chapuis in 2008 and is headquartered in Rillieux-la-Pape, France.

Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland.

Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France.

Vatel Capital SAS (Vatel Capital) is an independent private equity firm headquartered in Paris, France. It was founded in 2008 by Marc Meneau and Antoine Herbinet.

Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria.

Dzeta Conseil SASU (Dzeta Conseil) is an independent private equity firm headquartered in Paris, France. It was founded in 2009 by Claude Harmon.

Mérieux Equity Partners SAS (Mérieux Equity Partners or MxEP) is a Private Equity and Venture Capital firm, a subsidiary of Mérieux Développement SASU founded in 2009. The firm is headquartered in Lyon, France, with additional offices across the country.

Holding des Centres Point Vision SAS provides ophthalmic services. It offers initial diagnostics, consultation, and online appointments. The firm also specializes in the issuance of prescription for glasses, contact lenses, and refractive surgery for nearsightedness, farsightedness, and astigmatism. The company was founded by François Pelen, Patrice Pouts, and Raphaël Schnitzer in 2011 and is headquartered in Paris, France.

Insight Sip SAS provides design services and creative packaging solutions. It offers circuit miniaturization and system in package technology that enables product development in increasing functionality. The firm automates the development of the products portability and flexibility of its methodology for future design service solutions. The company was founded by Chris Baratt and Michel Beghin in 2005 and is headquartered in Sophia-Antipolis, France.

Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France.

Essling Capital SAS (Essling Capital) is an independent private equity firm founded in 2016 by Frank-Noël Vandenberghe. The firm is headquartered in Paris, France.

Physio-Assist SAS develops an expertise in bronchial mucus analysis and clearance. The company was founded by Adrien Mithalal on September 17, 2012 and is headquartered in Aix en Provence, France.

Medelse SAS operates as an internet recruitment platform for healthcare workers such as doctors, dentist, pharmacists, and radiologists. The company was founded by Tristan Renoul and Thomas Gendron on February 10, 2016 and is headquartered in Paris, France.

Sofia Développement SAS is a French company founded in 2019 and based in Paris, France. The company specializes in e-health and provides products and services to support health professionals in the digitalization of their profession, improving the efficiency of care. Sofia Développement SAS has 270 e-health experts at the service of 40,000 care professionals and manages 30,000 care sheets daily. The company has subsidiaries in France and has a turnover of €30 million annually. Sofia Développement SAS aims to transform care paths to provide better quality of life to the patient and nursing staff, improving performance and reducing the ineffectiveness of health systems. The company has a positive and comforting social climate and is looking for new talents to join their team. Geoffroy Lapointe has been the CEO of the company since 2021.

Intecmedia SAS, founded in 2007, is a company based in La Ciotat, France that specializes in e-health. The French company helps transform the role of pharmacists to become more involved in patient care. The company's solutions allow pharmacies to manage patient relationships in addition to their regular software. The company offers training to help users understand the benefits of their platform and how to use it effectively. The company also provides mobile applications for patients to stay connected with their pharmacy and schedule appointments. The company's websites serve as an extension of the patient experience beyond the physical pharmacy, providing access to products and services. The DigitecPharma platform is simple, intuitive, and interactive, allowing pharmacies to manage patients, organize services, and deploy new missions with their team.

Keenturtle is a French company that provides electronic health data services. The company is based in Paris, France. The company was founded in 2017 by David Vandecapelle, Francois Versini, Rock Pilven.